Physician profile
Hector L Morier
NPI 1053716043
$716.49
in general payments reported to CMS, 2019-2025
9 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $220 · 2023: $51.39 · 2024: $103 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $182.00 | 2022 | |
| Astellas Pharma US INC | $162.67 | 2024-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.78 | 2021-2025 | Jardiance |
| Biohaven Pharmaceuticals, INC. | $93.49 | 2021 | |
| Insightec,INC | $44.24 | 2025 | Exablate |
| Pfizer INC. | $37.65 | 2023 | |
| Lilly USA, LLC | $31.64 | 2024 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $13.74 | 2023 | Ozempic, Rybelsus |
| Amgen INC. | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Morier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.